Quotes About Generic drugs

Many countries which are no longer able to afford their public health systems, which have made certain promises within their countries to purchase from free market or from other economies, are approaching us seeking help with the supply of generic drugs, which is opening a very big room of opportunity for us.

One dirty tactic big pharmaceutical companies use is keeping drug prices artificially high through anti-competitive conduct, such as paying competitors millions of dollars to stop them from creating generic drugs.

One in every three pills taken by Americans, for example, are generics produced in India, which itself gets two-thirds of pharmaceutical ingredients from China.

In today's world, it is shortsighted to think that infectious diseases cannot cross borders. By allowing developing countries access to generic drugs, we not only help improve health in those nations, we also help ourselves control these debilitating and often deadly diseases.

We should look for ways to expedite generic drug approvals, particularly for products that have a long history of being safe and effective.

The value that the generic drug industry brings to the U.S. healthcare system is indisputable.

The regulatory approach of the Food and Drug Administration and the Patent and Trademark Office has driven up the costs of generic drugs.